alaproclate and morphine

alaproclate has been researched along with morphine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Calverley, PM; Carmichael, GL; Scott, DB1
Holm, AC; Ogren, SO1
Brodin, E; Franck, J; Rosén, A1

Reviews

1 review(s) available for alaproclate and morphine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for alaproclate and morphine

ArticleYear
Effects of alaproclate and morphine on the ventilatory response to carbon dioxide in normal man.
    British journal of anaesthesia, 1983, Volume: 55, Issue:9

    Topics: Adult; Alanine; Carbon Dioxide; Depression, Chemical; Drug Synergism; Humans; Male; Morphine; Respiration; Time Factors

1983

Other Studies

2 other study(ies) available for alaproclate and morphine

ArticleYear
Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Journal of neural transmission, 1980, Volume: 47, Issue:4

    Topics: Alanine; Analgesia; Animals; Behavior, Animal; Brompheniramine; Desipramine; Dose-Response Relationship, Drug; Male; Morphine; Naloxone; p-Chloroamphetamine; Pain; Pyridines; Rats; Serotonin; Zimeldine

1980
Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey.
    Neuropeptides, 1995, Volume: 28, Issue:6

    Topics: 5,7-Dihydroxytryptamine; Alanine; Animals; Cholecystokinin; Kinetics; Male; Morphine; Neurokinin A; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance P

1995